NCT06343428View on ClinicalTrials.gov

Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients

RecruitingOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

July 19, 2021

Primary Completion Date

July 19, 2024

Study Completion Date

July 19, 2026

Conditions

Neuroendocrine Neoplasm

Trial Locations (1)

20141

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER